NBL1 and small cell lung carcinoma: Another study indicated that ENO2 triggered the activation of the BMP2/Smad/ID1 signalling pathway through its interaction with NBL1, thereby gaining stem cell-like properties in small cell lung cancer cells (SCLC) [30].